{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:04:24Z","timestamp":1784869464231,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,23]]},"DOI":"10.7759\/cureus.113260","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:57:12Z","timestamp":1784869032000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Peripartum Cardiomyopathy With and Without Bromocriptine: A Comparative Study"],"prefix":"10.7759","author":[{"given":"Joseph","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeba Sharon","family":"Gnanaiah J.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishanth","family":"Isaac E.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Karunya  Kiran","family":"Gnanaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs J","year":"2019","unstructured":"Bauersachs J, K\u00f6nig T, van der Meer P, et al.. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019, 21:827-43. 10.1002\/ejhf.1493","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf193","article-title":"2025 ESC Guidelines for the management of cardiovascular disease and pregnancy","volume":"46","author":"De Backer J","year":"2025","unstructured":"De Backer J, Haugaa KH, Hasselberg NE, et al.. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J. 2025, 46:4462-568. 10.1093\/eurheartj\/ehaf193","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022, 145:e895-e1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.014","article-title":"Peripartum cardiomyopathy: JACC state-of-the-art review","volume":"75","author":"Davis MB","year":"2020","unstructured":"Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:207-21. 10.1016\/j.jacc.2019.11.014","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00664-8","article-title":"Pathophysiology and risk factors of peripartum cardiomyopathy","volume":"19","author":"Hoes MF","year":"2022","unstructured":"Hoes MF, Arany Z, Bauersachs J, Hilfiker-Kleiner D, Petrie MC, Sliwa K, van der Meer P. Pathophysiology and risk factors of peripartum cardiomyopathy. Nat Rev Cardiol. 2022, 19:555-65. 10.1038\/s41569-021-00664-8","journal-title":"Nat Rev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa455","article-title":"Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry","volume":"41","author":"Sliwa K","year":"2020","unstructured":"Sliwa K, Petrie MC, van der Meer P, et al.. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020, 41:3787-97. 10.1093\/eurheartj\/ehaa455","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3055","article-title":"Outcomes at one year in women with peripartum cardiomyopathy: findings from the ESC EORP PPCM registry","volume":"26","author":"Jackson AM","year":"2024","unstructured":"Jackson AM, Bauersachs J, Petrie MC, et al.. Outcomes at one year in women with peripartum cardiomyopathy: findings from the ESC EORP PPCM registry. Eur J Heart Fail. 2024, 26:34-42. 10.1002\/ejhf.3055","journal-title":"Eur J Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2264","article-title":"Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM registry","volume":"23","author":"Jackson AM","year":"2021","unstructured":"Jackson AM, Petrie MC, Frogoudaki A, et al.. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM registry. Eur J Heart Fail. 2021, 23:2058-69. 10.1002\/ejhf.2264","journal-title":"Eur J Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware JS","year":"2016","unstructured":"Ware JS, Li J, Mazaika E, et al.. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016, 374:233-41. 10.1056\/NEJMoa1505517","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner D","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E, et al.. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007, 128:589-600. 10.1016\/j.cell.2006.12.036","journal-title":"Cell"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2018:2:2","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy","volume":"4","author":"Koenig T","year":"2018","unstructured":"Koenig T, Bauersachs J, Hilfiker-Kleiner D. Bromocriptine for the treatment of peripartum cardiomyopathy. Card Fail Rev. 2018, 4:46-9. 10.15420\/cfr.2018:2:2","journal-title":"Card Fail Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner D","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D, et al.. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017, 38:2671-9. 10.1093\/eurheartj\/ehx355","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-015-0869-5","article-title":"Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy","volume":"104","author":"Haghikia A","year":"2015","unstructured":"Haghikia A, Podewski E, Berliner D, et al.. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy. Clin Res Cardiol. 2015, 104:911-7. 10.1007\/s00392-015-0869-5","journal-title":"Clin Res Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx428","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD","volume":"38","author":"Arrigo M","year":"2017","unstructured":"Arrigo M, Blet A, Mebazaa A. Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD. Eur Heart J. 2017, 38:2680-2. 10.1093\/eurheartj\/ehx428","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101461","article-title":"Prolactin inhibition in peripartum cardiomyopathy: systematic review and meta-analysis","volume":"48","author":"Kumar A","year":"2023","unstructured":"Kumar A, Ravi R, Sivakumar RK, et al.. Prolactin inhibition in peripartum cardiomyopathy: systematic review and meta-analysis. Curr Probl Cardiol. 2023, 48:101461. 10.1016\/j.cpcardiol.2022.101461","journal-title":"Curr Probl Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2023.07.028","article-title":"Proteomic profiling in patients with peripartum cardiomyopathy: a biomarker study of the ESC EORP PPCM registry","volume":"11","author":"Kodogo V","year":"2023","unstructured":"Kodogo V, Viljoen C, Hoevelmann J, et al.. Proteomic profiling in patients with peripartum cardiomyopathy: a biomarker study of the ESC EORP PPCM registry. JACC Heart Fail. 2023, 11:1708-25. 10.1016\/j.jchf.2023.07.028","journal-title":"JACC Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang RM","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al.. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015, 16:233-70. 10.1093\/ehjci\/jev014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany Z","year":"2016","unstructured":"Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016, 133:1397-409. 10.1161\/CIRCULATIONAHA.115.020491","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa K","year":"2010","unstructured":"Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al.. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010, 12:767-78. 10.1093\/eurjhf\/hfq120","journal-title":"Eur J Heart Fail"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.03.047","article-title":"Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management","volume":"58","author":"Elkayam U","year":"2011","unstructured":"Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011, 58:659-70. 10.1016\/j.jacc.2011.03.047","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.11.069","article-title":"Peripartum cardiomyopathy: a review article","volume":"164","author":"Karaye KM","year":"2013","unstructured":"Karaye KM, Henein MY. Peripartum cardiomyopathy: a review article. Int J Cardiol. 2013, 164:33-8. 10.1016\/j.ijcard.2011.11.069","journal-title":"Int J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2603","article-title":"A global perspective on the management and outcomes of peripartum cardiomyopathy: a\u00a0systematic review and meta-analysis","volume":"24","author":"Hoevelmann J","year":"2022","unstructured":"Hoevelmann J, Engel ME, Muller E, Hohlfeld A, B\u00f6hm M, Sliwa K, Viljoen C. A global perspective on the management and outcomes of peripartum cardiomyopathy: a\u00a0systematic review and meta-analysis. Eur J Heart Fail. 2022, 24:1719-36. 10.1002\/ejhf.2603","journal-title":"Eur J Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211857","article-title":"Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study","volume":"14","author":"Behrens I","year":"2019","unstructured":"Behrens I, Basit S, Lykke JA, et al.. Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study. PLoS One. 2019, 14:e0211857. 10.1371\/journal.pone.0211857","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10185-8","article-title":"Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis","volume":"27","author":"Trongtorsak A","year":"2022","unstructured":"Trongtorsak A, Kittipibul V, Mahabir S, Ibrahim M, Saint Croix GR, Hernandez GA, Chaparro S. Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis. Heart Fail Rev. 2022, 27:533-43. 10.1007\/s10741-021-10185-8","journal-title":"Heart Fail Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13352","article-title":"Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey","volume":"122","author":"Bernard N","year":"2015","unstructured":"Bernard N, Jantzem H, Becker M, et al.. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey. BJOG. 2015, 122:1244-51. 10.1111\/1471-0528.13352","journal-title":"BJOG"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/BF01727477","article-title":"Bromocriptine in pregnancy: safety aspects","volume":"65","author":"Krupp P","year":"1987","unstructured":"Krupp P, Monka C. Bromocriptine in pregnancy: safety aspects. Klin Wochenschr. 1987, 65:823-7. 10.1007\/BF01727477","journal-title":"Klin Wochenschr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69253-2","article-title":"Peripartum cardiomyopathy","volume":"368","author":"Sliwa K","year":"2006","unstructured":"Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006, 368:687-93. 10.1016\/S0140-6736(06)69253-2","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.01.043","article-title":"Meta-analysis of long-term (>1\u00a0year) cardiac outcomes of peripartum cardiomyopathy","volume":"194","author":"Koerber D","year":"2023","unstructured":"Koerber D, Khan S, Kirubarajan A, et al.. Meta-analysis of long-term (>1\u00a0year) cardiac outcomes of peripartum cardiomyopathy. Am J Cardiol. 2023, 194:71-7. 10.1016\/j.amjcard.2023.01.043","journal-title":"Am J Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.087387","article-title":"Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy","volume":"93","author":"Hu CL","year":"2007","unstructured":"Hu CL, Li YB, Zou YG, et al.. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart. 2007, 93:488-90. 10.1136\/hrt.2006.087387","journal-title":"Heart"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473530-management-of-peripartum-cardiomyopathy-with-and-without-bromocriptine-a-comparative-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:57:13Z","timestamp":1784869033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473530-management-of-peripartum-cardiomyopathy-with-and-without-bromocriptine-a-comparative-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.113260","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}